
Dydroboon 30mg Tablet SR
Marketer
Mankind Pharma Ltd
Salt Composition
Dydrogesterone (30mg)
Overview Dydroboon 30mg Tablet SR
Progestin-30 SR (30mg) tablets address various progesterone-related disorders, including infertility, menstrual pain, premenstrual syndrome (PMS), endometriosis, irregular uterine bleeding, and recurrent miscarriage. It's also employed in hormone replacement therapy. Dosage and treatment length for Progestin-30 SR are determined by your physician following a comprehensive evaluation (bloodwork, ultrasound, etc.) and are tailored to your specific condition. Self-medication is strongly discouraged. Maintain consistent daily intake, swallowing the tablet whole with water, to ensure treatment effectiveness. Complete the prescribed course for optimal results. Potential side effects, such as headaches, nausea, uterine bleeding, and breast tenderness, may occur. Intermenstrual bleeding is also possible. Consult your physician regarding management and prevention of these effects. Report any persistent or worsening symptoms. Prior to commencing Progestin-30 SR therapy, inform your doctor about any pre-existing conditions (diabetes, depression, cardiovascular or hepatic disease) and current medications, as interactions may occur. Pregnant or lactating individuals must consult their physician before use. Always seek medical advice for any concerns or questions.
Uses of Dydroboon 30mg Tablet SR
Managing infertility in women | Alleviating menstrual pain | Premenstrual syndrome (PMS) management | Endometriosis treatment | Addressing abnormal uterine bleeding | Preventing pregnancy loss | Hormone replacement therapy
Major Benefits of Dydroboon 30mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dydroboon 30mg Extended-Release Tablets can be consumed with or without food, although consistent daily timing is recommended.
Common Side effects of Dydroboon 30mg Tablet SR:
- Headache
- Nausea
- Breast pain
- Migraine
- Menstrual disorder
- Breast tenderness
- Vaginal bleeding
How to use Dydroboon 30mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Dydroboon 30mg sustained-release tablet can be consumed with or without food, though consistent timing is recommended.
How Dydroboon 30mg Tablet SR works:
Progestin-based Dydroboon 30mg SR tablets mimic the body's natural progesterone, thereby mitigating symptoms stemming from hormonal irregularities. By preparing the uterine lining, it aids fertility in women. Its action regulates menstrual cycles and reduces the risk of recurrent pregnancy loss, thus improving conception rates in women with a history of multiple miscarriages. Additionally, it provides relief from menstrual discomfort and cramps. Dydroboon 30mg SR also inhibits endometrial tissue growth, alleviating endometriosis symptoms such as lower abdominal and back pain, dyspareunia, bowel irregularities (constipation and diarrhea), and impaired fecundity.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dydroboon 30mg Tablet SR is not established as safe. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The extended-release Dydroboon 30mg tablet is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dydroboon 30mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a Dydroboon 30mg sustained-release tablet might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Dydroboon 30mg extended-release tablets in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Dydroboon 30mg sustained-release tablets to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dydroboon 30mg sustained-release tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Dydroboon 30mg Tablet SR :
Should you forget a Dydroboon 30mg Tablet SR dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dydroboon 30mg Tablet SR
| Label | Value |
|---|---|
| Chemical Category | Glucocorticoids, Mineralocorticoids, and Progestins |
| Developing Habits | No. |
| Treatment Category | OBSTETRIC AND GYNECOLOGICAL |
| Actions | First-Generation Progestins |
